Literature DB >> 30954988

Glycemic Control and Long-term Complications in Pediatric Onset Type 1 Diabetes Mellitus: A Single-center Experience from Northern India.

Siddhnath Sudhanshu1, Veena V Nair1, Tushar Godbole1, S Vijay Bhaskar Reddy1, Eesh Bhatia1, Preeti Dabadghao1, Kumudini Sharma2, Pratibha Arora1, Sayda Bano1, Anulina Singh1, Vijayalakshmi Bhatia3.   

Abstract

OBJECTIVE: To study glycemic control, mortality and long-term complications in children with type 1 diabetes (T1D).
DESIGN: Cross-sectional study.
SETTING: Referral centre at a government teaching hospital. PARTICIPANTS: Patients with T1D with age £18 years at onset.
METHODS: We retrospectively collected demographic data from computer records from 1991 to 2015. Prospective study for outcomes was conducted between 2012 and 2016. MAIN OUTCOME MEASURES: Mortality rate, glycosylated hemoglobin (HbA1c), and microvascular complication rate.
RESULTS: The proportion of T1D patients (n=512) <5 years of age at onset was 18.6% between 1995 and 2004, and 24.2% in 2005-2014 (P<0.001). Twenty eight patients had died out of 334 whose living status was known (mortality 1.1 per 100 patient-years over 2549 patient-years follow up). Median (range) HbA1c (n=257) was 8.3% (5.1-15.0%). At least one episode of severe hypoglycemia (coma/seizure/inability to assist self) had occurred in 22.8% patients over two years. Hypertension was present in 11.7% patients. Microvascular complications screen in 164 eligible patients [median (range) age 20 (8-45) y and duration of diabetes 9.1 (5-30) y] showed diabetic nephropathy in 3.0%, proliferative retinopathy in 3.6% and LDL cholesterol >100 mg/dL in 34% patients.
CONCLUSIONS: The mortality rate and prevalence of hypertension were high, given the short duration of diabetes of the patients. The proportion of patients with age ≤5 years at onset of diabetes has increased at our center.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30954988

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  1 in total

1.  Analysis of the improvement of serological indexes in patients with diabetic nephropathy and hypertension using Valsartan combined with Nifedipine controlled-release regimen.

Authors:  Lili Cai; Haili Zhu
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.